QC
ACIU icon

Quadrature Capital’s AC Immune ACIU Stock Holding History

Quadrature Capital’s Portfolio ACIU Stock Details ACIU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$30.9K Buy
+12,991
New +$35.8K ﹤0.01% 1530

Other funds holding ACIU

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
AC
AXQ Capital Jersey City, New Jersey $920M AUM 18.71% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BCV
Banque Cantonale Vaudoise Lausanne, Switzerland $722M AUM 30.45% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return

Quadrature Capital's ACIU Position: Q2 2026 in Review

Quadrature Capital opened a new position in AC Immune (ACIU) in Q2 2026: 12,991 shares worth $30.9K. The stake represents ﹤0.01% of the portfolio and ranks #1530 among its holdings.

20 funds tracked by Wall St. Rank hold ACIU as of Q2 2026.

  • Quadrature Capital held 12,991 shares of AC Immune worth $30.9K as of Q2 2026.
  • AC Immune was a new Quadrature Capital position in Q2 2026.
  • AC Immune made up ﹤0.01% of Quadrature Capital's portfolio in Q2 2026, its #1530 holding.
  • 20 funds tracked by Wall St. Rank held AC Immune as of Q2 2026.

Based on Quadrature Capital's 13F filing for Q2 2026, filed 7 Aug 2026.